IDEXX Laboratories, Inc. (NAS: IDXX) Stock Analysis & Fundamentals | ScreenerHero

Create free account

IDXXIDEXX Laboratories, Inc.

NAS · US · Healthcare · Diagnostics & Research · idexx.com

563.57USD+0.89%Mkt Cap: 44.46B $P/E: 41.53Today

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It opera…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$195.86BUSDP/E 28.9

Danaher Corporation

$140.88BUSDP/E 38.7

$46.71BUSDP/E 45.1

Agilent Technologies, Inc.

$37.93BUSDP/E 27.0

Waters Corporation

$36.96BUSDP/E 48.0

IQVIA Holdings Inc.

$34.69BUSDP/E 25.8

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.19BUSDP/E 30.4

Quest Diagnostics Incorporated

$22.96BUSDP/E 22.9

Labcorp Holdings Inc.

$22.70BUSDP/E 24.5

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.37BUSDP/E 33.9

Eurofins Scientific SE

$12.97BUSDP/E 27.0

$12.53BUSDP/E 54.0

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.01BUSDP/E 21.0

BillionToOne, Inc.

$5.83BUSDP/E 234.8

Twist Bioscience Corporation

Sotera Health Company

$5.25BUSDP/E 44.9

$4.55BUSDP/E 52.8

DiaSorin S.p.A.

$3.70BUSDP/E 26.1

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.54BUSDP/E 39.0

Diagnostyka S.A.

$1.55BUSDP/E 23.5

Personalis, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

OPKO Health, Inc.

Castle Biosciences, Inc.

$655.97MUSDP/E 42.7

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.91MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

Oxford BioDynamics Plc

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap44.46B $

Enterprise Value44.97B $

Revenue (TTM)4.45B $

Gross Profit2.66B $

Net Income (TTM)1.06B $

Revenue/Share55.57 USD

Last Price563.57 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees11.0K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS45168D1046

Valuation

P/E (Trailing)41.53

P/E (Forward)33.81

PEG3.56

EV/EBITDA29.09

EV/Revenue10.11

P/S9.91

P/B28.44

EPS (TTM)13.69

EPS (Forward)16.52

52W Range

506.9122% of range769.98

52W High769.98 USD

52W Low506.91 USD

Profitability

Gross Margin61.80%

Oper. Margin31.78%

EBITDA Margin34.77%

Profit Margin24.62%

ROE65.99%

ROA31.62%

Growth

Revenue Growth14.30%

Earnings Growth17.20%

Cash Flow & Leverage

Operating CF1.18B $

CapEx (TTM)138.23M $

FCF Margin17.70%

FCF Yield1.77%

Net Debt904.92M $

Net Debt/EBITDA0.59

Balance Sheet

Debt/Equity0.61

Current Ratio1.12

Quick Ratio0.69

Book Value/Sh19.64 USD

Cash/Share2.542 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split2:1

Split DateJun 16, 2015

Analyst Consensus

Rating2.1 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)709.14 USD

Upside (mean)+25.8%

Target Range470.00 USD – 805.00 USD

$470.00+25.8% to mean$805.00

# Analysts14

Ownership

Shares Out.78.88M

Float78.58M

Insiders0.22%

Institutions96.14%

Short Interest

Short Ratio3.5d

Short % Float3.10%

Short % Out.2.71%

Shares Short2.14M

Short (prev mo.)2.02M

Technical

SMA 50555.29 (+1.5%)

SMA 200626.31 (-10.0%)

Beta1.55

S&P 52W Chg20.11%

Avg Vol (30d)593.51K

Avg Vol (10d)779.65K

Technical Indicators

RSI (14)53.2

MACD0.1165

MACD Signal-1.9837

MACD Hist.+2.1002

BB Upper579.12 USD

BB Middle554.23 USD

BB Lower529.35 USD

BB Width8.98%

ATR (14)17.61 USD

Vol Ratio (20d)0.90x